Imaging biomarkers in multiple sclerosis

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Recent years have witnessed impressive advances in the use of magnetic resonance imaging (MRI) for the assessment of patients with multiple sclerosis (MS). Complementary to the clinical evaluation, conventional MRI provides crucial pieces of information for the diagnosis of MS. However, the correlation between the burden of lesions observed on conventional MRI scans and the clinical manifestations of the disease remains weak. The discrepancy between clinical and conventional MRI findings in MS is explained, at least partially, by the limited ability of conventional MRI to characterize and quantify the heterogeneous features of MS pathology. Other quantitative MR-based techniques, however, have the potential to overcome such a limitation of conventional MRI. Indeed, magnetization transfer MRI, diffusion tensor MRI, proton MR spectroscopy, and functional MRI are contributing to elucidate the mechanisms that underlie injury, repair, and functional adaptation in patients with MS. Such techniques are likely to benefit from the use of high-field MR systems and thus allow in the near future providing additional insight into all these aspects of the disease. This review summarizes how MRI is dramatically changing our understanding of the factors associated with the accumulation of irreversible disability in MS and highlights the reasons why they should be used more extensively in studies of disease evolution and clinical trials.

Original languageEnglish
Pages (from-to)770-788
Number of pages19
JournalJournal of Magnetic Resonance Imaging
Volume31
Issue number4
DOIs
Publication statusPublished - 2010

Fingerprint

Multiple Sclerosis
Biomarkers
Magnetic Resonance Imaging
Diffusion Magnetic Resonance Imaging
Protons
Magnetic Resonance Spectroscopy
Clinical Trials
Pathology
Wounds and Injuries

Keywords

  • Conventional MRI
  • Diffusion tensor MRI
  • Functional MRI
  • Magnetization transfer MRI
  • Multiple sclerosis
  • Proton MR spectroscopy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Imaging biomarkers in multiple sclerosis. / Filippi, M.; Agosta, F.

In: Journal of Magnetic Resonance Imaging, Vol. 31, No. 4, 2010, p. 770-788.

Research output: Contribution to journalArticle

@article{4feaf09e3a624201b0104da9178826e5,
title = "Imaging biomarkers in multiple sclerosis",
abstract = "Recent years have witnessed impressive advances in the use of magnetic resonance imaging (MRI) for the assessment of patients with multiple sclerosis (MS). Complementary to the clinical evaluation, conventional MRI provides crucial pieces of information for the diagnosis of MS. However, the correlation between the burden of lesions observed on conventional MRI scans and the clinical manifestations of the disease remains weak. The discrepancy between clinical and conventional MRI findings in MS is explained, at least partially, by the limited ability of conventional MRI to characterize and quantify the heterogeneous features of MS pathology. Other quantitative MR-based techniques, however, have the potential to overcome such a limitation of conventional MRI. Indeed, magnetization transfer MRI, diffusion tensor MRI, proton MR spectroscopy, and functional MRI are contributing to elucidate the mechanisms that underlie injury, repair, and functional adaptation in patients with MS. Such techniques are likely to benefit from the use of high-field MR systems and thus allow in the near future providing additional insight into all these aspects of the disease. This review summarizes how MRI is dramatically changing our understanding of the factors associated with the accumulation of irreversible disability in MS and highlights the reasons why they should be used more extensively in studies of disease evolution and clinical trials.",
keywords = "Conventional MRI, Diffusion tensor MRI, Functional MRI, Magnetization transfer MRI, Multiple sclerosis, Proton MR spectroscopy",
author = "M. Filippi and F. Agosta",
year = "2010",
doi = "10.1002/jmri.22102",
language = "English",
volume = "31",
pages = "770--788",
journal = "Journal of Magnetic Resonance Imaging",
issn = "1053-1807",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Imaging biomarkers in multiple sclerosis

AU - Filippi, M.

AU - Agosta, F.

PY - 2010

Y1 - 2010

N2 - Recent years have witnessed impressive advances in the use of magnetic resonance imaging (MRI) for the assessment of patients with multiple sclerosis (MS). Complementary to the clinical evaluation, conventional MRI provides crucial pieces of information for the diagnosis of MS. However, the correlation between the burden of lesions observed on conventional MRI scans and the clinical manifestations of the disease remains weak. The discrepancy between clinical and conventional MRI findings in MS is explained, at least partially, by the limited ability of conventional MRI to characterize and quantify the heterogeneous features of MS pathology. Other quantitative MR-based techniques, however, have the potential to overcome such a limitation of conventional MRI. Indeed, magnetization transfer MRI, diffusion tensor MRI, proton MR spectroscopy, and functional MRI are contributing to elucidate the mechanisms that underlie injury, repair, and functional adaptation in patients with MS. Such techniques are likely to benefit from the use of high-field MR systems and thus allow in the near future providing additional insight into all these aspects of the disease. This review summarizes how MRI is dramatically changing our understanding of the factors associated with the accumulation of irreversible disability in MS and highlights the reasons why they should be used more extensively in studies of disease evolution and clinical trials.

AB - Recent years have witnessed impressive advances in the use of magnetic resonance imaging (MRI) for the assessment of patients with multiple sclerosis (MS). Complementary to the clinical evaluation, conventional MRI provides crucial pieces of information for the diagnosis of MS. However, the correlation between the burden of lesions observed on conventional MRI scans and the clinical manifestations of the disease remains weak. The discrepancy between clinical and conventional MRI findings in MS is explained, at least partially, by the limited ability of conventional MRI to characterize and quantify the heterogeneous features of MS pathology. Other quantitative MR-based techniques, however, have the potential to overcome such a limitation of conventional MRI. Indeed, magnetization transfer MRI, diffusion tensor MRI, proton MR spectroscopy, and functional MRI are contributing to elucidate the mechanisms that underlie injury, repair, and functional adaptation in patients with MS. Such techniques are likely to benefit from the use of high-field MR systems and thus allow in the near future providing additional insight into all these aspects of the disease. This review summarizes how MRI is dramatically changing our understanding of the factors associated with the accumulation of irreversible disability in MS and highlights the reasons why they should be used more extensively in studies of disease evolution and clinical trials.

KW - Conventional MRI

KW - Diffusion tensor MRI

KW - Functional MRI

KW - Magnetization transfer MRI

KW - Multiple sclerosis

KW - Proton MR spectroscopy

UR - http://www.scopus.com/inward/record.url?scp=77950906842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950906842&partnerID=8YFLogxK

U2 - 10.1002/jmri.22102

DO - 10.1002/jmri.22102

M3 - Article

VL - 31

SP - 770

EP - 788

JO - Journal of Magnetic Resonance Imaging

JF - Journal of Magnetic Resonance Imaging

SN - 1053-1807

IS - 4

ER -